We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NeoTract Gets De Novo Clearance for First Permanent Implant for BPH
NeoTract Gets De Novo Clearance for First Permanent Implant for BPH
September 20, 2013
The FDA has cleared NeoTract’s UroLift system as the first permanent implant to relieve low or blocked urine flow in men 50 and older with an enlarged prostate.